ABSTRACT
Emerging excipients are increasingly becoming integral parts of sophisticated drug delivery systems rather than functioning as ‘‘stand-alone’’ chemical entities. Such systems require complex manufacturing methodologies and precise chemical/clinical engineering protocols to achieve the desired morphology of the drug-excipient recipe-mere mechanical incorporation of drug and excipient into a formulation rarely achieves the desired outcome.
